Arthritis Society Canada / Société de l’arthrite du Canada
Registration:
5
of
9
(2021-03-31
to
2022-10-17)
Grant, Contribution or Other Financial Benefit, Policies or Program
- Funding from the federal government for research related to arthritis and to support patient oriented research
Legislative Proposal, Bill or Resolution
- Discussions with government officials with respect to the legalization and regulation of marijuana as it relates to medical cannabis policy
Legislative Proposal, Bill or Resolution, Regulation
- Employment Insurance Act, specifically with respect to episodic disabilities and/or caregivers
- Food and Drugs Act and Regulations, specifically with respect to the special access programme for patients living with arthritis
Policies or Program
- Advocacy for development of a coordinated national strategy for musculoskeletal conditions that will align strategic directions, exchange best practices and integration of prevention, detection and management systems across Canada
- Communication with federal government officials with respect to promoting research and federal-provincial coordination in best practices for arthritis patient care
- Engagement with the Advisory Committee on the Implementation of National Pharmacare and its Secretariat on issues related to medicines for chronic diseases, such as arthritis
- Health Canada's office of pharmaceutical management strategies, specifically with respect to Health Canada's role in supporting and directing federal, national and inter-jurisdictional pharmaceutical policy
- Promoting workplace productivity and wellness initiatives for musculoskeletal health
Policies or Program, Regulation
- Excise Tax Act, specifically with respect to the application of sales tax on medical cannabis
Regulation
- Canada Pension Plan, specifically the term "severe and prolonged" in s. 42 to broaden its application to more Canadians.
- Patented Medicine Prices Review Board, specifically with respect to the regulation of pricing of patented drug products